Renalytix
RenalytixAI is a developer of artificial intelligence-enabled clinical diagnostic solutions for kidney health.
Business Model:
Revenue: $3M
Employees: 2-10
Industries / Tags:
Detailed Renalytix Information
Geographic Data
Address: 1460 Broadway
City: New York
State: NY
Zip: 10036
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$21M
Raised Total:$45M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
RenalytixAI is a developer of artificial intelligence (AI) enabled clinical diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI’s solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care, and patient stratification for drug clinical trials. RenalytixAI’s technology platform will draw from distinct sources of patient data, including large electronic health records, predictive blood-based biomarkers, and other genomic information for analysis by learning computer algorithms. RenalytixAI intends to build a deep, unique pool of kidney disease-related data for different AI-enabled applications designed to improve predictive capability and clinical utility over time.
Contact Phone:
+18014472698
Contact Email:
Renalytix went public on 11/6/2018 on the London Stock Exchange
Listed Exchange:
London Stock Exchange
IPO Date:
11/6/2018
IPO Valuation:
$85M
Ticker Symbol:
RENX
IPO Price:
$1.5867562244119167/share
Amount Raised:
$33M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2022 | Post-IPO Debt | 4 | $21.2M |
Ann E. Berman Christopher Mills Thomas McLain Timothy J. Scannell Ann E. Berman Christopher Mills Thomas McLain Timothy J. Scannell |
4/2022 | Post-IPO Equity | 4 | $8.8M |
Ann E. Berman Christopher Mills Thomas McLain Timothy J. Scannell Ann E. Berman Christopher Mills Thomas McLain Timothy J. Scannell |
1/2023 | Grant | 1 | $10M |
Horizon Europe Horizon Europe |
2/2023 | Private Placement | $15.1M | 7/2019 | Post-IPO Equity | $17.4M | 11/2018 | Series A | $29M | 4/2022 | Post-IPO Debt | $30M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
